Nonetheless, the ACE2 cross-reactive S1-RBD mAbs found in this study provide valuable reagents to address the contribution of these ACE2 cross-reactive S1-RBD antibodies in the immunopathogenesis of COVID-19 during SARS-CoV-2 infection in the future. The gene discussed is PSMD1; the disease is COVID-19.